Sandhill Capital Partners LLC Gamida Cell Ltd. Transaction History

Sandhill Capital Partners LLC

  • $1.2 Billion
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023
BUY
$0.85 - $1.87 $12,107 - $26,636
14,244 New
14,244 $14,000
Q2 2023

Aug 08, 2023
BUY
$0.73 - $2.37 $1,825 - $5,925
2,500 Added 21.29%
14,244 $27,000
Q1 2023

May 12, 2023
BUY
$0.68 - $1.71 $7,985 - $20,082
11,744 New
11,744 $9,000

Others Institutions Holding GMDA

# of Institutions
58
Shares Held
11.4M
Call Options Held
235K
Put Options Held
70.5K
View Full List

About Gamida Cell Ltd.

GMDA Quotes by TradingView
  • Ticker GMDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,319,600
  • Market Cap $2.29M
  • Description
  • Gamida Cell Ltd., a clinical-stage biopharmaceutical company, develops cell therapies to cure blood cancers and serious hematologic diseases. The company's lead product candidate is omidubicel, a cell therapy that has completed Phase III clinical trial in patients with high-risk hematologic malignancies, as well as in Phase I/II clinical trials ...
More about GMDA
Track This Portfolio

Track Sandhill Capital Partners LLC Portfolio

Follow Sandhill Capital Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sandhill Capital Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sandhill Capital Partners LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email